RecruitingPhase 2NCT07036796

Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy

Studying OBSOLETE: Acquired metabolic neuropathy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Ain Shams University
Intervention: Melatonin(drug)
Enrollment: 60 target
Eligibility: 40-75 years · All sexes
Timeline: 2025 – 2026

Study locations (1)

Ain Shams University hospital, Cairo, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07036796 on ClinicalTrials.gov

Other trials for OBSOLETE: Acquired metabolic neuropathy

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07496398
Median and Ulnar Nerve Function in Tattoo Artists
Gazi University
ENROLLING BY INVITATIONNANCT07126197
Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy
National Taiwan University Hospital
RECRUITINGNANCT07095998
Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy
Ka-Wai Ho
RECRUITINGNCT06483620
Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire
Cairo University
RECRUITINGNANCT06158529
High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain
Fan BiFa
RECRUITINGNANCT06287736
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
Ohio State University
RECRUITINGNANCT06488963
The Effect of Cold Therapy on Peripheral Neuropathy
Koç University
RECRUITINGNANCT04909138
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
Rush University Medical Center

See all trials for OBSOLETE: Acquired metabolic neuropathy →

← Back to all trials